Results 161 to 170 of about 606,742 (218)

Hamman's crunch—A pathognomonic sign of pneumomediastinum

open access: yesEquine Veterinary Education, Volume 38, Issue 9, Page e571-e576, September 2026.
Summary Pneumomediastinum, particularly spontaneous pneumomediastinum, is uncommon and presents a diagnostic challenge. In human medicine, auscultation of Hamman's crunch, a crepitant, crunching noise, audible over the cardiac region in synchrony with the heartbeat, is considered pathognomonic for pneumomediastinum.
S. McCullagh   +4 more
wiley   +1 more source

Computed Tomographic and Clinical Findings in Domestic Rabbits (Oryctolagus cuniculus domesticus) with Pulmonary Emphysema. [PDF]

open access: yesVet Radiol Ultrasound
Athinodorou A   +5 more
europepmc   +1 more source

The 2025 ATS/ERS update of the international multidisciplinary classification of the interstitial pneumonias: implications for the pathologist

open access: yesHistopathology, Volume 89, Issue 3, Page 403-425, September 2026.
This review highlights changes relevant to pathologists in the updated multidisciplinary classification of interstitial pneumonias. Changes include expansion beyond idiopathic disease, subclassification as interstitial (fibrotic vs non‐fibrotic) and alveolar filling disorders, expansion to include additional patterns (e.g.
Andrew G Nicholson   +7 more
wiley   +1 more source

Carbocisteine Reduces Airway Mucus Obstruction and Alters Inflammatory Cell Populations in a Model of Muco‐Obstructive Lung Disease

open access: yesImmunology &Cell Biology, Volume 104, Issue 8, Page 833-844, September 2026.
Mice with a muco‐obstructive lung disease phenotype were treated with the mucoactive drug, carbocisteine, which resulted in reduced airway mucus and an alteration in the lung mononuclear cell population which was either as a direct effect of, or secondary to, improved mucus clearance.
Peter Ferris   +6 more
wiley   +1 more source

Unusual lung adenocarcinoma spread along with pulmonary emphysema. [PDF]

open access: yesRespirol Case Rep, 2021
Miyamura T   +3 more
europepmc   +1 more source

Idiopathic Pulmonary Fibrosis update, comparing the Australasian Interstitial Lung Disease Registry to the Australian Idiopathic Pulmonary Fibrosis Registry

open access: yesInternal Medicine Journal, Volume 56, Issue 9, Page 1518-1527, September 2026.
Abstract Background and aims Real‐world evaluation of clinical characteristics and treatment profile of patients with idiopathic pulmonary fibrosis (IPF) is needed to establish areas for improvement according to evidence‐based recommendations. This study evaluated the clinical characteristics and treatment profile of patients with IPF from the ...
Michelle Chee   +31 more
wiley   +1 more source

Home - About - Disclaimer - Privacy